New cell therapy shows promise for Hard-to-Treat myeloma
NCT ID NCT05182073
First seen Jan 05, 2026 · Last updated Apr 29, 2026 · Updated 20 times
Summary
This early-stage study tested a new cell therapy called FT576, given alone or with another drug (daratumumab), in 31 people with multiple myeloma that had come back or stopped responding to prior treatments. The main goals were to find the safest dose and check for side effects. Researchers also looked at whether the treatment shrank the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
City of Hope
Duarte, California, 91010, United States
-
Indiana University
Indianapolis, Indiana, 46202, United States
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Medical Oncology Hematology Consultants
Newark, Delaware, 19713, United States
-
Oncology Hematology Care, Inc
Cincinnati, Ohio, 45226, United States
-
Roswell Park
Buffalo, New York, 14263, United States
-
Scri-Cbci
Denver, Colorado, 80218, United States
-
Tennessee Oncology - Nashville
Nashville, Tennessee, 37203, United States
-
Texas Oncology-Medical City Dallas
Dallas, Texas, 75230, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35205, United States
-
University of Minnesota
Saint Paul, Minnesota, 55108, United States
-
Virginia Oncology Associates
Norfolk, Virginia, 23502, United States
-
Washington University
St Louis, Missouri, 63130, United States
Conditions
Explore the condition pages connected to this study.